Last reviewed · How we verify
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer (pompom)
This trial is a multi-center, randomized, open, parallel-group and positive-controlled phase III trial to evaluate the efficacy and safety of paclitaxel polymeric micelles for injection plus gemcitabine as first-line treatment of metastatic pancreatic cancer compared with nab-Paclitaxel plus gemcitabine.
Details
| Lead sponsor | Shanghai Yizhong Pharmaceutical Co., Ltd. |
|---|---|
| Phase | PHASE3 |
| Status | RECRUITING |
| Enrolment | 416 |
| Start date | Wed Feb 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pancreatic Cancer Metastatic
Interventions
- paclitaxel polymeric micelles for injection
- Gemcitabine Hydrochloride for Injection
- Paclitaxel for Injection (albumin bound )
- Gemcitabine Hydrochloride for Injection
Countries
China